查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1645725

全球藥用塞劑市場按類型、基礎、配方類型、治療用途、填充類別、年齡層、分銷管道和最終用戶分類 - 機會分析和行業預測，2024 年至 2035 年

Pharmaceutical Suppositories Market By Type, By Base, By Prescription Type, By Therapeutic Application, By Fill Volume Categories, By Age Group, By Distribution Channel, By End User : Global Opportunity Analysis and Industry Forecast, 2024-2035
出版日期: | 出版商: Allied Market Research | 英文 423 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2023 年藥用塞劑市場價值估計為 16.6809 億美元，預計到 2035 年將達到 32.3932 億美元，2024 年至 2035 年的複合年成長率為 5.7%。

醫藥供應市場-IMG1

藥用塞劑是固態劑型，用於插入體腔，在體腔中溶解或熔化以釋放活性成分。它們通常使用可可脂、甘油明膠和聚乙二醇 (PEG) 等基質配製而成，以提供穩定性並允許控制藥物釋放。製造過程包括熔化基質、將其與活性藥物成分 (API) 和任何所需的賦形劑混合，並將混合物形成所需的形狀。冷卻後栓劑凝固，包裝備用。塞劑旨在透過黏膜吸收來輸送藥物。

藥用塞劑市場因多種關鍵因素而不斷成長。老年人常難以吞嚥錠劑，需要局部給藥。此外，胃腸道疾病和某些癌症等慢性疾病的發生率不斷上升，對塞劑所能提供的標靶治療的需求也日益成長。藥物傳遞技術的進一步進步擴大了可透過塞劑給藥的藥物範圍和有效性。例如，美國國家醫學圖書館於 2023 年發表的一項研究表明，與兒科人群中的口服給藥相比，透過直腸途徑給藥的阿奇黴素栓劑的生物有效性顯著提高。此外，政府提倡早期診斷的措施和製藥公司提高公眾對塞劑益處的認知的努力也進一步推動了市場的成長。

然而，也存在一些阻礙市場擴張的挑戰。有限的藥物相容性仍然是一個問題，因為由於溶解度問題，並非所有藥物都能透過塞劑持續或有效地輸送。此外，複雜的製造流程需要專門的設備，這增加了生產成本並限制了製造商的數量。這些因素限制了市場准入、增加了成本並影響了整體承受能力。儘管有這些挑戰，但由於塞劑在藥物傳遞方面的獨特優勢，其需求仍在持續上升。

藥用塞劑市場分為類型、基礎、配方類型、治療用途、填充類別、年齡層、成分類型、分銷管道和地區。根據類型，市場分為直腸塞劑、陰道塞劑和尿道塞劑。依基質不同，可分為脂肪族基質、水溶性基質、乳化基質。水溶性基質又分為甘油明膠基質、皂甘油栓劑基質、聚乙二醇基質等。乳化基進一步分為Witepsol、Massaesterium和Massapol。依劑型類型，栓劑分為OTC塞劑和處方塞劑。依治療用途，分為止痛藥/抗發炎藥、止吐藥、瀉藥、荷爾蒙療法、抗黴菌/抗菌藥等。依填充量類別分為小填充量、中填充量、大填充量。依年齡層別分為兒童版和成人版。根據成分類型，它們被分為原料藥和輔料。依銷售管道可分為醫院藥局、零售藥局、網路銷售。根據最終用戶，市場分為醫院/診所、居家醫療和其他。根據地區，市場分析涵蓋北美、歐洲、亞太、拉丁美洲、中東和非洲。

相關人員的主要利益

  • 該報告定量分析了 2023 年至 2035 年藥用塞劑市場分析的市場細分、當前趨勢、估計和動態，並確定了藥用塞劑市場的突出機會。
  • 它為市場研究提供與市場促進因素、市場限制因素和市場機會相關的資訊。
  • 波特五力分析強調了買家和供應商的力量，幫助相關人員做出以利潤為導向的商業決策，並加強供應商-買家網路。
  • 藥用塞劑市場細分的詳細分析有助於確定市場機會。
  • 每個地區的主要國家都根據收益貢獻進行分類。
  • 市場公司的定位有利於基準化分析，並能清楚了解市場公司的當前地位。
  • 報告包括區域和全球藥用塞劑市場趨勢、主要企業、細分市場、應用領域和市場成長策略的分析。

此報告可進行客製化（可能需要支付額外費用和製定時間表）

  • 根據客戶興趣加入公司簡介
  • 擴展公司簡介列表
  • 歷史市場資料
  • 導入/匯出分析/資料

目錄

第 1 章 簡介

第 2 章執行摘要

第3章 市場概況

  • 市場定義和範圍
  • 主要發現
    • 關鍵影響因素
    • 重大投資機會
  • 波特五力分析
  • 市場動態
    • 驅動程式
      • 急性和慢性疾病盛行率上升
      • 老年人口不斷增加
      • 加強對塞劑使用的認知與教育力道
    • 限制因素
      • 製造藥用塞劑的複雜性
      • 塞劑的儲存和穩定性問題
    • 機會
      • 製劑技術的進步

第4章 藥用塞劑市場（按類型）

  • 概述
  • 直腸栓劑
  • 陰道栓劑

第 5 章 藥用塞劑市場（依基礎）

  • 概述
  • 脂肪基
  • 水溶性基質
    • 水溶性藥用塞劑市場（按類型分類）
  • 乳化基料
    • 乳化型藥用塞劑市場（按類型分類）

6. 藥用塞劑市場（依劑型分類）

  • 概述
  • 非處方藥
  • 處方栓劑

第7章 藥用塞劑市場（依治療用途）

  • 概述
  • 止痛藥和消炎藥
  • 止吐藥
  • 瀉藥
  • 荷爾蒙療法
  • 抗真菌藥物和抗菌藥物
  • 其他

8. 藥用塞劑市場（依灌裝量分類）

  • 概述
  • 小體積包裝
  • 中等容量灌裝機
  • 大容量包裝材料

第 9 章 藥用塞劑市場（依年齡層）

  • 概述
  • 兒科
  • 對於成年人

第 10 章 藥用塞劑市場（依分銷管道）

  • 概述
  • 醫院藥房
  • 藥局和零售藥局
  • 線上提供者

第 11 章 藥用塞劑市場（依最終用戶）

  • 概述
  • 醫院和診所
  • 居家醫療
  • 其他

第12章 藥用塞劑市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 其他
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 其他
  • 拉丁美洲
    • 拉丁美洲
    • 中東和非洲

第13章 競爭格局

  • 介紹
  • 關鍵成功策略
  • 前 10 家公司的產品映射
  • 競爭儀錶板
  • 競爭熱圖
  • 2023年主要企業的定位

第14章 公司簡介

  • Intas Pharmaceuticals Ltd.
  • Pfizer Inc.
  • Church & Dwight Co. Inc.
  • Zydus Lifesciences Limited
  • Bayer AG
  • Novartis AG
  • Sanofi SA
  • Bliss GVS Pharma Ltd
  • Bausch Health Companies Inc.
  • Cosette Pharmaceuticals, Inc.
簡介目錄
Product Code: A12350

The pharmaceutical suppositories market was valued for $1,668.09 million in 2023 and is estimated to reach $3,239.32 million by 2035, exhibiting a CAGR of 5.7% from 2024 to 2035.

Pharmaceutical Suppositories Market - IMG1

Pharmaceutical suppositories are solid dosage forms designed for insertion into body cavities, where they dissolve or melt to release active ingredients. They are commonly formulated using a base material such as cocoa butter, glycerinated gelatin, or polyethylene glycol (PEG) and others, which provides stability and enables controlled drug release. The manufacturing process involves melting the base, mixing it with the active pharmaceutical ingredient (API) and any necessary excipients, and then molding the mixture into the desired shape. Once cooled, the suppositories solidify and are packaged for use. Suppositories are designed to deliver medication via mucosal absorption.

The pharmaceutical suppositories market is growing due to several key factors. The aging global population is driving demand, as elderly individuals often struggle with swallowing pills or require localized drug delivery. Additionally, the rising prevalence of chronic diseases like gastrointestinal disorders and certain cancers increases the need for targeted treatments that suppositories can provide. Further advancements in drug delivery have expanded the range of medications administered via suppositories, enhancing their effectiveness. For instance, a study published by National Library of Medicine in 2023, stated that, an azithromycin suppository administered through the rectal route demonstrated significantly increased bioavailability when compared with oral administration in pediatric population. Moreover, government initiatives promoting early diagnosis, along with pharmaceutical companies' efforts to raise public awareness of suppository benefits, further support market growth.

However, certain challenges hinder market expansion. Limited drug compatibility remains an issue, as not all medications are stable or effectively delivered through suppositories due to solubility concerns. Moreover, the complex manufacturing processes require specialized equipment, which increases production costs and limits the number of manufacturers. These factors contribute to restricted market accessibility and higher costs, impacting overall affordability. Despite these challenges, the demand for suppositories continues to rise, driven by their unique advantages in drug delivery.

The pharmaceutical suppositories market is segmented into type, base, prescription type, therapeutic application, fill volume categories, age group, ingredient type, distribution channel, and region. On the basis of type, the market is divided into rectal suppositories, vaginal suppositories and urethral suppositories. According to base, it is classified into fatty base, water miscible bases, and emulsifying bases. The water miscible bases are further segmented into glycero gelatin base, soap glycerin suppositories, and polyethylene glycol bases. The emulsifying bases are further segmented into witepsol, massa esterium, and massuppol. On the basis of prescription type, it is bifurcated into OTC and prescribed suppositories. On the basis of therapeutic application, it is categorized into analgesics and anti-inflammatory drugs, antiemetics, laxatives, hormonal therapies, antifungals and antibacterials, and others. As per fill volume categories, it is divided into small fill volumes, medium fill volumes, and large fill volumes. On the basis of age group, it is bifurcated into pediatric use, and adult use. Depending on ingredient type, it is classified into active pharmaceutical ingredients, and excipients. On the basis of distribution channel, the market is divided into hospital pharmacies, retail pharmacies and online sales. On the basis of end user, the market is categorized into hospitals and clinics, home care, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The major players that operate in the pharmaceutical suppositories market include Zydus group, Bayer AG, Church & Dwight Co. Inc, Cosette Pharmaceuticals, Inc., Intas Pharmaceuticals Ltd., Novartis AG, Pfizer Inc., Sanofi S.A, Bliss GVS Pharma Ltd, and Bausch Health Companies Inc. The key players have adopted strategies such as product approval to expand their product portfolio.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pharmaceutical suppositories market analysis from 2023 to 2035 to identify the prevailing pharmaceutical suppositories market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the pharmaceutical suppositories market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global pharmaceutical suppositories market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data
  • Import Export Analysis/Data

Key Market Segments

By Prescription Type

  • OTC
  • Prescribed Suppositories

By Therapeutic Application

  • Analgesics and Anti-Inflammatory Drugs
  • Antiemetics
  • Laxatives
  • Hormonal Therapies
  • Antifungals and Antibacterials
  • Others

By Fill Volume Categories

  • Small Fill Volumes
  • Medium Fill Volumes
  • Large Fill Volumes

By Type

  • Rectal Suppositories
  • Vaginal Suppositories

By Age Group

  • Pediatric Use
  • Adult Use

By Base

  • Fatty Bases
  • Water Miscible Base
    • Type
    • Glycero Gelatin Base
    • Soap Glycerin Suppositories
    • Polyethylene Glycol Bases
  • Emulsifying Bases
    • Type
    • Witepsol
    • Massa Esterium
    • Massuppol

By Distribution Channel

  • Hospital Pharmacies
  • Drug Stores and Retail Pharmacies
  • Online Providers

By End User

  • Hospitals and Clinics
  • Home Care
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Rest of Asia-Pacific
  • LAMEA
    • Latin America
    • Middle East And Africa

Key Market Players:

    • Bausch Health Companies Inc.
    • Bayer AG
    • Bliss GVS Pharma Ltd
    • Church & Dwight Co. Inc.
    • Cosette Pharmaceuticals, Inc.
    • Intas Pharmaceuticals Ltd.
    • Novartis AG
    • Pfizer Inc.
    • Sanofi S.A.
    • Zydus Lifesciences Limited

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Moderate bargaining power of suppliers
    • 3.3.2. Moderate threat of new entrants
    • 3.3.3. Moderate threat of substitutes
    • 3.3.4. Moderate intensity of rivalry
    • 3.3.5. Moderate bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
      • 3.4.1.1. Rise in prevalence of acute & chronic disorders
      • 3.4.1.2. Increase in the geriatric population
      • 3.4.1.3. Increase in initiatives for awareness and education for use of suppositories
    • 3.4.2. Restraints
      • 3.4.2.1. Manufacturing complexities of pharmaceutical suppositories
      • 3.4.2.2. Storage and stability issues of pharmaceutical suppositories
    • 3.4.3. Opportunities
      • 3.4.3.1. Technological advancements in formulation technology

CHAPTER 4: PHARMACEUTICAL SUPPOSITORIES MARKET, BY TYPE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Rectal Suppositories
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Vaginal Suppositories
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country

CHAPTER 5: PHARMACEUTICAL SUPPOSITORIES MARKET, BY BASE

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. Fatty Bases
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Water Miscible Base
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
    • 5.3.4. Water Miscible Base Pharmaceutical Suppositories Market by Type
  • 5.4. Emulsifying Bases
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country
    • 5.4.4. Emulsifying Bases Pharmaceutical Suppositories Market by Type

CHAPTER 6: PHARMACEUTICAL SUPPOSITORIES MARKET, BY PRESCRIPTION TYPE

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. OTC
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Prescribed Suppositories
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country

CHAPTER 7: PHARMACEUTICAL SUPPOSITORIES MARKET, BY THERAPEUTIC APPLICATION

  • 7.1. Overview
    • 7.1.1. Market size and forecast
  • 7.2. Analgesics and Anti-Inflammatory Drugs
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by region
    • 7.2.3. Market share analysis by country
  • 7.3. Antiemetics
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by region
    • 7.3.3. Market share analysis by country
  • 7.4. Laxatives
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by region
    • 7.4.3. Market share analysis by country
  • 7.5. Hormonal Therapies
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by region
    • 7.5.3. Market share analysis by country
  • 7.6. Antifungals and Antibacterials
    • 7.6.1. Key market trends, growth factors and opportunities
    • 7.6.2. Market size and forecast, by region
    • 7.6.3. Market share analysis by country
  • 7.7. Others
    • 7.7.1. Key market trends, growth factors and opportunities
    • 7.7.2. Market size and forecast, by region
    • 7.7.3. Market share analysis by country

CHAPTER 8: PHARMACEUTICAL SUPPOSITORIES MARKET, BY FILL VOLUME CATEGORIES

  • 8.1. Overview
    • 8.1.1. Market size and forecast
  • 8.2. Small Fill Volumes
    • 8.2.1. Key market trends, growth factors and opportunities
    • 8.2.2. Market size and forecast, by region
    • 8.2.3. Market share analysis by country
  • 8.3. Medium Fill Volumes
    • 8.3.1. Key market trends, growth factors and opportunities
    • 8.3.2. Market size and forecast, by region
    • 8.3.3. Market share analysis by country
  • 8.4. Large Fill Volumes
    • 8.4.1. Key market trends, growth factors and opportunities
    • 8.4.2. Market size and forecast, by region
    • 8.4.3. Market share analysis by country

CHAPTER 9: PHARMACEUTICAL SUPPOSITORIES MARKET, BY AGE GROUP

  • 9.1. Overview
    • 9.1.1. Market size and forecast
  • 9.2. Pediatric Use
    • 9.2.1. Key market trends, growth factors and opportunities
    • 9.2.2. Market size and forecast, by region
    • 9.2.3. Market share analysis by country
  • 9.3. Adult Use
    • 9.3.1. Key market trends, growth factors and opportunities
    • 9.3.2. Market size and forecast, by region
    • 9.3.3. Market share analysis by country

CHAPTER 10: PHARMACEUTICAL SUPPOSITORIES MARKET, BY DISTRIBUTION CHANNEL

  • 10.1. Overview
    • 10.1.1. Market size and forecast
  • 10.2. Hospital Pharmacies
    • 10.2.1. Key market trends, growth factors and opportunities
    • 10.2.2. Market size and forecast, by region
    • 10.2.3. Market share analysis by country
  • 10.3. Drug Stores and Retail Pharmacies
    • 10.3.1. Key market trends, growth factors and opportunities
    • 10.3.2. Market size and forecast, by region
    • 10.3.3. Market share analysis by country
  • 10.4. Online Providers
    • 10.4.1. Key market trends, growth factors and opportunities
    • 10.4.2. Market size and forecast, by region
    • 10.4.3. Market share analysis by country

CHAPTER 11: PHARMACEUTICAL SUPPOSITORIES MARKET, BY END USER

  • 11.1. Overview
    • 11.1.1. Market size and forecast
  • 11.2. Hospitals and Clinics
    • 11.2.1. Key market trends, growth factors and opportunities
    • 11.2.2. Market size and forecast, by region
    • 11.2.3. Market share analysis by country
  • 11.3. Home Care
    • 11.3.1. Key market trends, growth factors and opportunities
    • 11.3.2. Market size and forecast, by region
    • 11.3.3. Market share analysis by country
  • 11.4. Others
    • 11.4.1. Key market trends, growth factors and opportunities
    • 11.4.2. Market size and forecast, by region
    • 11.4.3. Market share analysis by country

CHAPTER 12: PHARMACEUTICAL SUPPOSITORIES MARKET, BY REGION

  • 12.1. Overview
    • 12.1.1. Market size and forecast By Region
  • 12.2. North America
    • 12.2.1. Key market trends, growth factors and opportunities
    • 12.2.2. Market size and forecast, by Type
    • 12.2.3. Market size and forecast, by Base
    • 12.2.4. Market size and forecast, by Prescription Type
    • 12.2.5. Market size and forecast, by Therapeutic Application
    • 12.2.6. Market size and forecast, by Fill Volume Categories
    • 12.2.7. Market size and forecast, by Age Group
    • 12.2.8. Market size and forecast, by Distribution Channel
    • 12.2.9. Market size and forecast, by End User
    • 12.2.10. Market size and forecast, by country
      • 12.2.10.1. U.S.
      • 12.2.10.1.1. Market size and forecast, by Type
      • 12.2.10.1.2. Market size and forecast, by Base
      • 12.2.10.1.3. Market size and forecast, by Prescription Type
      • 12.2.10.1.4. Market size and forecast, by Therapeutic Application
      • 12.2.10.1.5. Market size and forecast, by Fill Volume Categories
      • 12.2.10.1.6. Market size and forecast, by Age Group
      • 12.2.10.1.7. Market size and forecast, by Distribution Channel
      • 12.2.10.1.8. Market size and forecast, by End User
      • 12.2.10.2. Canada
      • 12.2.10.2.1. Market size and forecast, by Type
      • 12.2.10.2.2. Market size and forecast, by Base
      • 12.2.10.2.3. Market size and forecast, by Prescription Type
      • 12.2.10.2.4. Market size and forecast, by Therapeutic Application
      • 12.2.10.2.5. Market size and forecast, by Fill Volume Categories
      • 12.2.10.2.6. Market size and forecast, by Age Group
      • 12.2.10.2.7. Market size and forecast, by Distribution Channel
      • 12.2.10.2.8. Market size and forecast, by End User
      • 12.2.10.3. Mexico
      • 12.2.10.3.1. Market size and forecast, by Type
      • 12.2.10.3.2. Market size and forecast, by Base
      • 12.2.10.3.3. Market size and forecast, by Prescription Type
      • 12.2.10.3.4. Market size and forecast, by Therapeutic Application
      • 12.2.10.3.5. Market size and forecast, by Fill Volume Categories
      • 12.2.10.3.6. Market size and forecast, by Age Group
      • 12.2.10.3.7. Market size and forecast, by Distribution Channel
      • 12.2.10.3.8. Market size and forecast, by End User
  • 12.3. Europe
    • 12.3.1. Key market trends, growth factors and opportunities
    • 12.3.2. Market size and forecast, by Type
    • 12.3.3. Market size and forecast, by Base
    • 12.3.4. Market size and forecast, by Prescription Type
    • 12.3.5. Market size and forecast, by Therapeutic Application
    • 12.3.6. Market size and forecast, by Fill Volume Categories
    • 12.3.7. Market size and forecast, by Age Group
    • 12.3.8. Market size and forecast, by Distribution Channel
    • 12.3.9. Market size and forecast, by End User
    • 12.3.10. Market size and forecast, by country
      • 12.3.10.1. Germany
      • 12.3.10.1.1. Market size and forecast, by Type
      • 12.3.10.1.2. Market size and forecast, by Base
      • 12.3.10.1.3. Market size and forecast, by Prescription Type
      • 12.3.10.1.4. Market size and forecast, by Therapeutic Application
      • 12.3.10.1.5. Market size and forecast, by Fill Volume Categories
      • 12.3.10.1.6. Market size and forecast, by Age Group
      • 12.3.10.1.7. Market size and forecast, by Distribution Channel
      • 12.3.10.1.8. Market size and forecast, by End User
      • 12.3.10.2. France
      • 12.3.10.2.1. Market size and forecast, by Type
      • 12.3.10.2.2. Market size and forecast, by Base
      • 12.3.10.2.3. Market size and forecast, by Prescription Type
      • 12.3.10.2.4. Market size and forecast, by Therapeutic Application
      • 12.3.10.2.5. Market size and forecast, by Fill Volume Categories
      • 12.3.10.2.6. Market size and forecast, by Age Group
      • 12.3.10.2.7. Market size and forecast, by Distribution Channel
      • 12.3.10.2.8. Market size and forecast, by End User
      • 12.3.10.3. UK
      • 12.3.10.3.1. Market size and forecast, by Type
      • 12.3.10.3.2. Market size and forecast, by Base
      • 12.3.10.3.3. Market size and forecast, by Prescription Type
      • 12.3.10.3.4. Market size and forecast, by Therapeutic Application
      • 12.3.10.3.5. Market size and forecast, by Fill Volume Categories
      • 12.3.10.3.6. Market size and forecast, by Age Group
      • 12.3.10.3.7. Market size and forecast, by Distribution Channel
      • 12.3.10.3.8. Market size and forecast, by End User
      • 12.3.10.4. Rest of Europe
      • 12.3.10.4.1. Market size and forecast, by Type
      • 12.3.10.4.2. Market size and forecast, by Base
      • 12.3.10.4.3. Market size and forecast, by Prescription Type
      • 12.3.10.4.4. Market size and forecast, by Therapeutic Application
      • 12.3.10.4.5. Market size and forecast, by Fill Volume Categories
      • 12.3.10.4.6. Market size and forecast, by Age Group
      • 12.3.10.4.7. Market size and forecast, by Distribution Channel
      • 12.3.10.4.8. Market size and forecast, by End User
  • 12.4. Asia-Pacific
    • 12.4.1. Key market trends, growth factors and opportunities
    • 12.4.2. Market size and forecast, by Type
    • 12.4.3. Market size and forecast, by Base
    • 12.4.4. Market size and forecast, by Prescription Type
    • 12.4.5. Market size and forecast, by Therapeutic Application
    • 12.4.6. Market size and forecast, by Fill Volume Categories
    • 12.4.7. Market size and forecast, by Age Group
    • 12.4.8. Market size and forecast, by Distribution Channel
    • 12.4.9. Market size and forecast, by End User
    • 12.4.10. Market size and forecast, by country
      • 12.4.10.1. Japan
      • 12.4.10.1.1. Market size and forecast, by Type
      • 12.4.10.1.2. Market size and forecast, by Base
      • 12.4.10.1.3. Market size and forecast, by Prescription Type
      • 12.4.10.1.4. Market size and forecast, by Therapeutic Application
      • 12.4.10.1.5. Market size and forecast, by Fill Volume Categories
      • 12.4.10.1.6. Market size and forecast, by Age Group
      • 12.4.10.1.7. Market size and forecast, by Distribution Channel
      • 12.4.10.1.8. Market size and forecast, by End User
      • 12.4.10.2. China
      • 12.4.10.2.1. Market size and forecast, by Type
      • 12.4.10.2.2. Market size and forecast, by Base
      • 12.4.10.2.3. Market size and forecast, by Prescription Type
      • 12.4.10.2.4. Market size and forecast, by Therapeutic Application
      • 12.4.10.2.5. Market size and forecast, by Fill Volume Categories
      • 12.4.10.2.6. Market size and forecast, by Age Group
      • 12.4.10.2.7. Market size and forecast, by Distribution Channel
      • 12.4.10.2.8. Market size and forecast, by End User
      • 12.4.10.3. India
      • 12.4.10.3.1. Market size and forecast, by Type
      • 12.4.10.3.2. Market size and forecast, by Base
      • 12.4.10.3.3. Market size and forecast, by Prescription Type
      • 12.4.10.3.4. Market size and forecast, by Therapeutic Application
      • 12.4.10.3.5. Market size and forecast, by Fill Volume Categories
      • 12.4.10.3.6. Market size and forecast, by Age Group
      • 12.4.10.3.7. Market size and forecast, by Distribution Channel
      • 12.4.10.3.8. Market size and forecast, by End User
      • 12.4.10.4. Rest of Asia-Pacific
      • 12.4.10.4.1. Market size and forecast, by Type
      • 12.4.10.4.2. Market size and forecast, by Base
      • 12.4.10.4.3. Market size and forecast, by Prescription Type
      • 12.4.10.4.4. Market size and forecast, by Therapeutic Application
      • 12.4.10.4.5. Market size and forecast, by Fill Volume Categories
      • 12.4.10.4.6. Market size and forecast, by Age Group
      • 12.4.10.4.7. Market size and forecast, by Distribution Channel
      • 12.4.10.4.8. Market size and forecast, by End User
  • 12.5. LAMEA
    • 12.5.1. Key market trends, growth factors and opportunities
    • 12.5.2. Market size and forecast, by Type
    • 12.5.3. Market size and forecast, by Base
    • 12.5.4. Market size and forecast, by Prescription Type
    • 12.5.5. Market size and forecast, by Therapeutic Application
    • 12.5.6. Market size and forecast, by Fill Volume Categories
    • 12.5.7. Market size and forecast, by Age Group
    • 12.5.8. Market size and forecast, by Distribution Channel
    • 12.5.9. Market size and forecast, by End User
    • 12.5.10. Market size and forecast, by country
      • 12.5.10.1. Latin America
      • 12.5.10.1.1. Market size and forecast, by Type
      • 12.5.10.1.2. Market size and forecast, by Base
      • 12.5.10.1.3. Market size and forecast, by Prescription Type
      • 12.5.10.1.4. Market size and forecast, by Therapeutic Application
      • 12.5.10.1.5. Market size and forecast, by Fill Volume Categories
      • 12.5.10.1.6. Market size and forecast, by Age Group
      • 12.5.10.1.7. Market size and forecast, by Distribution Channel
      • 12.5.10.1.8. Market size and forecast, by End User
      • 12.5.10.2. Middle East And Africa
      • 12.5.10.2.1. Market size and forecast, by Type
      • 12.5.10.2.2. Market size and forecast, by Base
      • 12.5.10.2.3. Market size and forecast, by Prescription Type
      • 12.5.10.2.4. Market size and forecast, by Therapeutic Application
      • 12.5.10.2.5. Market size and forecast, by Fill Volume Categories
      • 12.5.10.2.6. Market size and forecast, by Age Group
      • 12.5.10.2.7. Market size and forecast, by Distribution Channel
      • 12.5.10.2.8. Market size and forecast, by End User

CHAPTER 13: COMPETITIVE LANDSCAPE

  • 13.1. Introduction
  • 13.2. Top winning strategies
  • 13.3. Product mapping of top 10 player
  • 13.4. Competitive dashboard
  • 13.5. Competitive heatmap
  • 13.6. Top player positioning, 2023

CHAPTER 14: COMPANY PROFILES

  • 14.1. Intas Pharmaceuticals Ltd.
    • 14.1.1. Company overview
    • 14.1.2. Key executives
    • 14.1.3. Company snapshot
    • 14.1.4. Operating business segments
    • 14.1.5. Product portfolio
  • 14.2. Pfizer Inc.
    • 14.2.1. Company overview
    • 14.2.2. Key executives
    • 14.2.3. Company snapshot
    • 14.2.4. Operating business segments
    • 14.2.5. Product portfolio
    • 14.2.6. Business performance
  • 14.3. Church & Dwight Co. Inc.
    • 14.3.1. Company overview
    • 14.3.2. Key executives
    • 14.3.3. Company snapshot
    • 14.3.4. Operating business segments
    • 14.3.5. Product portfolio
    • 14.3.6. Business performance
  • 14.4. Zydus Lifesciences Limited
    • 14.4.1. Company overview
    • 14.4.2. Key executives
    • 14.4.3. Company snapshot
    • 14.4.4. Operating business segments
    • 14.4.5. Product portfolio
    • 14.4.6. Business performance
    • 14.4.7. Key strategic moves and developments
  • 14.5. Bayer AG
    • 14.5.1. Company overview
    • 14.5.2. Key executives
    • 14.5.3. Company snapshot
    • 14.5.4. Operating business segments
    • 14.5.5. Product portfolio
    • 14.5.6. Business performance
  • 14.6. Novartis AG
    • 14.6.1. Company overview
    • 14.6.2. Key executives
    • 14.6.3. Company snapshot
    • 14.6.4. Operating business segments
    • 14.6.5. Product portfolio
    • 14.6.6. Business performance
  • 14.7. Sanofi S.A.
    • 14.7.1. Company overview
    • 14.7.2. Key executives
    • 14.7.3. Company snapshot
    • 14.7.4. Operating business segments
    • 14.7.5. Product portfolio
    • 14.7.6. Business performance
  • 14.8. Bliss GVS Pharma Ltd
    • 14.8.1. Company overview
    • 14.8.2. Key executives
    • 14.8.3. Company snapshot
    • 14.8.4. Operating business segments
    • 14.8.5. Product portfolio
    • 14.8.6. Business performance
  • 14.9. Bausch Health Companies Inc.
    • 14.9.1. Company overview
    • 14.9.2. Key executives
    • 14.9.3. Company snapshot
    • 14.9.4. Operating business segments
    • 14.9.5. Product portfolio
    • 14.9.6. Business performance
  • 14.10. Cosette Pharmaceuticals, Inc.
    • 14.10.1. Company overview
    • 14.10.2. Key executives
    • 14.10.3. Company snapshot
    • 14.10.4. Operating business segments
    • 14.10.5. Product portfolio